Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
about
Chronic allopurinol treatment during the last trimester of pregnancy in sows: effects on low and normal birth weight offspringBreastmilk-Saliva Interactions Boost Innate Immunity by Regulating the Oral Microbiome in Early InfancyAllopurinol: insights from studies of dose-response relationships.Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of goutPharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.Allopurinol reduces antigen-specific and polyclonal activation of human T cells.The pharmacokinetics of oxypurinol in people with gout.Predicting allopurinol response in patients with goutAllopurinol, uric acid, and oxidative stress in cardiorenal disease.Pharmacokinetics considerations for gout treatments.The role of urate and xanthine oxidase in vascular oxidative stress: future directions.A pilot in distress.Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations.Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure.Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour.Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics.Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.The population pharmacokinetics of allopurinol and oxypurinol in patients with goutComparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis
P2860
Q28539019-BB7C6B95-15D8-4168-B0D9-0F4F37346832Q28547679-0C3EDCB2-D871-4A18-9EC9-8CB49D0FF86EQ30240163-9FB4CF2D-0EFE-45E8-8041-0F73ECF15929Q34476295-0791FA07-C42D-410E-BEA7-D499D8F4EE8DQ36053872-FE19CB68-73B6-485E-9B51-116A221361DFQ36250232-388EA2AE-08BE-4BA2-AB4F-E30BA19DF211Q36336035-B778CB19-0867-486E-B1FC-500F086BB2F1Q36802064-A9E67224-262E-467E-831A-614D7055CC50Q37872639-58109F1D-2046-4E8D-9AE7-F5814BE7CAFEQ38210284-E3564401-11C2-4B6F-909B-977CD82A7311Q39936328-D369EFC6-C90F-4792-9793-78493B0CC19CQ40333585-38F81A63-D202-4D8C-8D21-970905F710CDQ43605904-23CF4C0B-C668-4ADB-9643-F55AEE17BBFCQ45120611-2DAE4881-1637-4CCE-92EB-EF5FAB52E11EQ50482094-F86A09C1-3DFB-4B2B-9332-2B22CE3BC64DQ51746631-A5FCDD5C-3480-41C7-A4CF-87B93A2A29D1Q52749977-6CF410F5-A4F5-430B-BD02-20BD2489F970Q57154764-9287B3F3-6FA2-4179-884E-C3E0F5BCB63FQ57170834-42AE46AB-E59D-42EF-B871-1BE2B3FA8B75
P2860
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@ast
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@en
type
label
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@ast
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@en
prefLabel
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@ast
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@en
P2093
P1476
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
@en
P2093
Bergendal L
Birkett DJ
McLachlan AJ
P304
P356
10.1046/J.1365-2125.1996.03116.X
P407
P577
1996-04-01T00:00:00Z